| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.97▼ | 0.95▲ | 0.96▲ | 0.95▲ | 0.80▲ |
| MA10 | 0.97▼ | 0.96▲ | 0.96▲ | 0.82▲ | 0.63▲ |
| MA20 | 0.96▲ | 0.97▼ | 0.99▼ | 0.74▲ | 0.68▲ |
| MA50 | 0.97▲ | 0.95▲ | 0.87▲ | 0.56▲ | 0.99▼ |
| MA100 | 0.98▼ | 0.85▲ | 0.76▲ | 0.68▲ | 1.09▼ |
| MA200 | 0.97▼ | 0.74▲ | 0.70▲ | 0.95▲ | 1.23▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.004▼ | -0.013▼ | 0.031▲ | 0.068▲ |
| RSI | 51.564▲ | 50.473▲ | 53.125▲ | 64.573▲ | 57.296▲ |
| STOCH | 50.848 | 21.574 | 24.548 | 77.950 | 66.585 |
| WILL %R | -36.408 | -65.222 | -81.030▼ | -27.113 | -17.895▲ |
| CCI | 31.155 | 16.322 | -34.274 | 106.611▲ | 150.604▲ |
|
Monday, November 10, 2025 06:15 AM
Continued rollout of FemBloc, the breakthrough non-surgical permanent contraceptive solution, expands the Company’s presence in key European Markets -- ATLANTA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ...
|
|
Monday, November 03, 2025 06:37 AM
Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval -- -- $12 million senior secured ...
|
|
Thursday, October 23, 2025 09:20 PM
(RTTNews) - Biotech stocks led the after-hours charge on Thursday, with Inhibrx Biosciences (INBX) skyrocketing over 81% on positive Phase 2 trial results in chondrosarcoma. Femasys (FEMY), Cingulate ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/11/25 | 1.025 | 1.025 | 0.9401 | 0.9663 | 4,279,094 |
| 11/11/25 | 0.99 | 1.11 | 0.93 | 0.941 | 5,982,000 |
| 10/11/25 | 0.91 | 1.11 | 0.82 | 1.04 | 12,877,645 |
| 07/11/25 | 0.78 | 1.05 | 0.78 | 1.04 | 13,754,093 |
| 06/11/25 | 0.85 | 0.899 | 0.756 | 0.781 | 8,525,000 |
| 05/11/25 | 0.7251 | 0.8785 | 0.7014 | 0.835 | 16,607,810 |
| 04/11/25 | 0.62 | 0.72 | 0.61 | 0.684 | 6,763,900 |
| 03/11/25 | 0.805 | 0.879 | 0.62 | 0.657 | 91,528,100 |
| 31/10/25 | 0.626 | 0.644 | 0.603 | 0.637 | 699,600 |
| 30/10/25 | 0.624 | 0.65 | 0.611 | 0.621 | 1,027,500 |
|
|
||||
|
|
||||
|
|